Achieve Life Sciences (ACHV) Asset Utilization Ratio (2011 - 2016)
Achieve Life Sciences' (ACHV) quarterly Asset Utilization Ratio came in at 0.37 in Q1 2016, up 12.89% YoY from 0.33 in Q2 2015, and up 28.3% on a QoQ basis from 0.29 in Q4 2015.
Achieve Life Sciences (ACHV) Asset Utilization Ratio (2011 - 2016) Analysis & Trends
Achieve Life Sciences (ACHV) has 6 years of Asset Utilization Ratio data on file, last reported at 0.37 in Q1 2016.
- Quarterly Asset Utilization Ratio rose 12.89% year-over-year to 0.37 in Q1 2016, while the trailing twelve-month figure through Mar 2016 was 0.37 (up 12.89% YoY) and the FY2015 annual result came in at 0.32, down 34.5% from the prior year.
- Asset Utilization Ratio grew to 0.37 in Q1 2016, from 0.29 in the prior quarter.
- In the past five years, Asset Utilization Ratio ranged from a high of 0.71 in Q2 2014 to a low of 0.06 in Q2 2012.
- A 5-year average of 0.36 and a median of 0.33 in 2015 frame the typical range for Asset Utilization Ratio.
- Annual changes were most pronounced in 2013 — Asset Utilization Ratio surged 596.14% — and 2015, when it sank 59.05%.
- Tracing ACHV's Asset Utilization Ratio over 5 years: stood at 0.22 in 2012, then soared by 127.11% to 0.51 in 2013, then dropped by 10.49% to 0.46 in 2014, then sank by 37.0% to 0.29 in 2015, then grew by 28.3% to 0.37 in 2016.
- The last three Asset Utilization Ratio figures came in at 0.37 (Q1 2016), 0.29 (Q4 2015), and 0.27 (Q3 2015), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 0.47 |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 0.38 |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 0.69 |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 186.67 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 0.13 |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 0.90 |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 0.54 |
| 10 | Achieve Life Sciences | 330.88 Mn | 330.88 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2016 | 0.37 |
| Dec 31, 2015 | 0.29 |
| Sep 30, 2015 | 0.27 |
| Jun 30, 2015 | 0.29 |
| Mar 31, 2015 | 0.33 |
| Dec 31, 2014 | 0.46 |
| Sep 30, 2014 | 0.54 |
| Jun 30, 2014 | 0.71 |
| Mar 31, 2014 | 0.69 |
| Dec 31, 2013 | 0.51 |
| Sep 30, 2013 | 0.47 |
| Jun 30, 2013 | 0.38 |
| Mar 31, 2013 | 0.30 |
| Dec 31, 2012 | 0.22 |
| Sep 30, 2012 | 0.11 |
| Jun 30, 2012 | 0.06 |
| Mar 31, 2012 | 0.06 |
| Dec 31, 2011 | 0.08 |
| Sep 30, 2011 | 0.09 |